Roche Pharmaceuticals A/S: Financial statements 2022
CVR: 25230515
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Roche Pharmaceuticals A/S (CVR 25230515) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 785,584,000 and a net result of DKK 19,560,000 compared with DKK 16,253,000 the year before. That is an increase of 7.2% compared with the year before. The profit margin was 2.5%. Equity in the 2022 report amounted to DKK 163,047,000. The solvency ratio was 41.8%. The company had 103 employees in the financial year.
- Revenue
- DKK 785,584,000
- Gross Profit
- DKK 149,085,000
- Profit/Loss
- DKK 19,560,000
- Equity
- DKK 163,047,000
- Total Assets
- DKK 389,676,000
- Employees
- 103
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 785.6M | 149.1M | 19.6M | 163M | 103 |
| 2021 | 732.8M | 133M | 16.3M | 143.5M | 110 |
| 2020 | 701.9M | 126.9M | 12.3M | 127.2M | 121 |
| 2019 | 718.2M | 126.1M | 21.8M | 159.9M | 121 |
| 2018 | 808.2M | 152.9M | 30.2M | 138.2M | 120 |
Official annual report
Keep an eye on Roche Pharmaceuticals A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of November 1, 2022, Isabel Marianne Joerin has joined the board of directors of Roche Pharmaceuticals A/S.
As of November 1, 2022, Beat Christoph Krähenmann has left the board of directors of Roche Pharmaceuticals A/S.
On October 28, 2022, the company changed its name from ROCHE A/S. MEDICINALVARER & KEMIKALIER to Roche Pharmaceuticals A/S.
Roche Pharmaceuticals A/S has published its annual report for 2021. Revenue came to DKK 732,832,000, and the net result was DKK 16,253,000.
About Roche Pharmaceuticals A/S
Roche Pharmaceuticals A/S is a Danish company of the type Aktieselskab based in København V, founded in 1970. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ROCHE A/S. MEDICINALVARER & KEMIKALIER. The management consists of Carole Hassoun. The board consists of Isabel Marianne Joerin (chair), Carole Hassoun and Ehab Abdelmoneim Youssef Hassan. The company is owned by Roche Holding AG. The company has 96 employees (2026). In 2025, the company reported revenue of DKK 928,824,000 and a net result of DKK 31,319,000 compared with DKK 24,277,000 the year before. Equity in the 2025 report amounted to DKK 195,179,000.